Important Safety Information Prescribing Information Patient Prescribing Information Print This Page
Sign up for updates

Do You Have ED?

Is erectile dysfunction (ED) preventing you from having a healthy sex life?

Do you have concerns about:

  • Getting an erection?
  • Having an erection firm enough for sex?
  • Staying firm after entering your partner?
  • Maintaining a firm erection until you are finished?

These are standard questions that a healthcare provider may ask you. If you answered "yes" to any of these, you should talk to your healthcare provider. Together, you should be able to figure out if you have ED, what may be causing it, and what to do about it.

More than half of all men over 40 have some difficulty getting and maintaining an erection*
*This fact from Feldman HA et al is from a study titled, "Impotence and its medical and psychological correlates: Results of the Massachusetts male aging study," and were reported in the Journal of Urology, volume 151 in January of 1994.


CAVERJECT is used to treat erectile dysfunction (ED) due to neurogenic, vasculogenic, psychogenic, or mixed etiology.


Important Safety Information

CAVERJECT should not be used in men hypersensitive to alprostadil, men with conditions that may predispose them to priapism (such as sickle cell anemia or trait, multiple myeloma or leukemia), men with anatomical deformities of the penis (such as angulation, cavernosal fibrosis or Peyronie’s disease), men with penile implants, or men for whom sexual activity is inadvisable or is contraindicated.

CAVERJECT should not be used in women, children or newborns.

Patients should be instructed to immediately report to his physician any erection lasting 4 hours or longer. If unavailable, patient must seek immediate medical assistance.

CAVERJECT can cause penile fibrosis or Peyronie’s disease.

Use of Caverject in patients who take anticoagulants, such as warfarin or heparin, should be with precaution as they may have increased tendency for bleeding after Caverject injections.

The most common side effect of CAVERJECT® (alprostadil for injection) was penile pain, reported by 37% of patients in clinical studies. Other side effects were prolonged erection, penile fibrosis and injection site hematoma. To lower the risk of prolonged erections or priapism, Caverject should be titrated slowly to the lowest effective dose.

For Full Prescribing and Patient Information for CAVERJECT®, please click here.